PHM-Exch> IMP. Sign-On to COVID-19: Principles for Global Access, Innovation and Cooperation, ahead of G20 Meeting of Health Ministers on 19-20 April

[prerna]

---------- Forwarded message ---------
From: Sangeeta Shashikant <sangeeta at twnetwork.org>

Hi everyone,

Please get support for the COVID-19: Principles for Global Access,
Innovation and Cooperation using this signature page
https://form.jotform.com/201005416725141



Sangeeta

TWN



*From:* Peter Maybarduk <pmaybarduk at citizen.org>
*Sent:* Monday, April 13, 2020 8:41 AM
*To:* covid-19-access <covid-19-access at listserver.citizen.org>
*Subject:* Principles: Help us reach allies this week, ahead of G20



Hey friends,

More than eighty groups (and a number of individuals) have signed on to the
principles so far. Check that yours is signed on below. This week we are
going to reach a little further into the global health and development
communities, and would welcome your help. Please circulate the principles
among your allies, all of whom can sign on at:
https://form.jotform.com/201005416725141. Deepika Yadav dyadav at citizen.org
is coordinating the effort.



G20 health ministers are meeting on April 19-20. We will deliver the
principles with signatures via the C20 (civil society) before then. But we
also intend to leave the signature form open, continue to collect
signatories and seek further opportunities for their use. Thank you!



*COVID-19: Principles for Global Access, Innovation and Cooperation*



COVID-19 has no nation and no ethnicity. If the pandemic goes unattended in
one country, it will accelerate beyond that country’s borders, potentially
overwhelming the world’s ability to respond.



Nationalistic responses to COVID-19 are ineffective. Countries must
urgently work together to ramp up the production of all medical
countermeasures, from masks and ventilators to tests, treatments and
vaccines, and ensure that everyone receives the medical attention they
need. We must tend not only to COVID-19 and its symptoms, but to people’s
ongoing and underlying health needs, which will become more acute as the
pandemic runs its course.



There is real danger that access to medical breakthroughs addressing
COVID-19 will be restricted by nation, by price, by limited production and
fragmented supply lines, and by exclusivity and commercial confidentiality.
We must prevent this – and help change medical innovation, health and
nationalism – by moving corporations, health agencies and governments to
share medical technology, invest in public manufacturing capacity and
promote access for all.



We are concerned that powerful countries may favor their drug corporations
and hoard medical tools at the expense of global cooperation. We are
concerned that privileged individuals who receive tests, treatments and
vaccines first may not be those who need them most. We stand in solidarity
with those disproportionately affected by factors such as health status,
geography, age, gender or race.



We call on governments, agencies, manufacturers, donors and development
partners to commit to:



*Innovation for all**: *Monopoly-based drug development is failing the
world. Governments should support open science and research practices for
health needs that align innovation and timely access. Technology owners
should commit patents, trade secrets, know-how, cell lines,
copyright, software, data, and all other relevant intellectual property to
the public domain. Access and affordability should be integral requirements
of the entire research and development (R&D) and manufacturing process.



*Access for all**: *Medical tools urgently needed to diagnose, treat,
mitigate and prevent COVID-19 should be accessible and available to all
without delay, with necessary priority given to healthcare workers and
vulnerable populations. Governments must ensure that diagnostics,
treatments, devices, vaccines, and personal protective equipment are priced
fairly and affordably to healthcare payers and are free to the public at
the point of care in all countries.  Corporations and other intellectual
property holders must suspend enforcement of exclusivities.



*Solidarity and global cooperation**: *Governments, technology owners and
researchers should urgently coordinate with the World Health Organization
to organize platforms for the public sharing of R&D outcomes, data,
know-how and intellectual property to accelerate innovation, quickly
scale-up production and mitigate shortages and supply chain vulnerability.
Medical tools must be manufactured for the public in robust supply to
meet unprecedented global need and promptly distributed across borders.

*Good governance and transparency:* Governments and
international organizations should promote transparency and meaningful
civil society participation in critical decision-making processes. Funders
and technology developers should ensure that costs related to R&D and
manufacturing as well as pricing, regulatory status and intellectual
property claims all are published transparently.

Signed:

1.       AIHTA

2.       Council of Canadians

3.       ARAS - Romanian Association Against AIDS

4.       AIDS Healthcare Foundation

5.       The Democracy Collaborative

6.       Naturefriends Greece

7.       A , INITIATIVEW FOR HEALTH & EQUITY IN SOCIETY   (2)All India Drug
Action Network

8.       Faith in Healthcare

9.       Center for Popular Democracy

10.   Citizen Action of Wisconsin

11.   Bangladesh Krishok Federation

12.   IT for Change

13.   Fairwatch

14.   Center for Economic Justice

15.   European Alliance for Responsible R&D and Affordable Medicines

16.   Salud por Derecho

17.   Groupe sida Genève

18.   Asociación por un Acceso Justo al Medicamento (AAJM)

19.   Wemos

20.   Health GAP (Global Access Project)

21.   Global Humanitarian Progress Corp.

22.   Indivisible

23.   Commons Network

24.   American Medical Student Association

25.   STOPAIDS

26.   Altroconsumo

27.   100%LIFE

28.   European Alternatives

29.   EPSU

30.   sula batsu coop

31.   Institute for Agriculture & Trade Policy

32.   DiEM25

33.   University of Aberdeen

34.   Médecins Sans Frontières Access Campaign

35.   AIDES

36.   Just Treatment

37.   KEPKA - Consumers' Protection Center

38.   Consumers Protection Association

39.   Gen-ethisches Netzwerk e.V.

40.   Corporate Europe Observatory (CEO)

41.   Policy Analysis and Research Institute of Lesotho (PARIL)

42.   Australian Fair Trade and Investment Network

43.   Chronic Illness Advocacy & Awareness Group

44.   Chronic Illness Advocacy & Awareness Group

45.   Consumer Association the Quality of Life-EKPIZO

46.   Public Eye

47.   Initiative for Medicines, Access & Knowledge (I-MAK)

48.   KEI

49.   Universities Allied for Essential Medicines.

50.   OXFAM

51.   Salud y Farmacos USA

52.   Third World Network

53.   Médecins Sans Frontières Access Campaign

54.   Prescrire

55.   International Treatment Preparedness Coalition Latin American and
Caribbean ITPC-LATCA.

56.   Global Health Advocates

57.   T1International

58.   Korean Pharmacists for Democratic Society(KPDS)

59.   Pharmaceutical Accountability Foundation

60.   Global Justice Now

61.   Asociación por un Acceso Justo al Medicamento (AAJM)



62.   AIDS Action Europe

63.   Campaign for Personal Prescription Importation

64.   Attac France

65.   Treatment Action Group

66.   ReAct–Action on Antibiotic Resistance

67.   Aitec

68.   Ivy foundation

69.   Focus on the Global South

70.   Standing Committee of European Doctors (CPME)

71.   Access to Medicines Research Group, China

72.   Africa Japan Forum

73.   Organisation for Sustainable Socio-Economic development Initiative in
Malawi

74.   Malawi Health Equity Network (MHEN)

75.   Women’s Network for Unity

76.   Social Action for Community and Development

77.   Nelson Mandela TB HIV Community Information and Resource Center CBO

78.   People's Health Institute

79.   CLIC, Northeastern University School of Law's Center for Law
Innovation and Creativity

80.   Access to Medicines Ireland
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://phm.phmovement.org/pipermail/phm-exchange-phmovement.org/attachments/20200414/08957482/attachment.html>